Radiotherapy versus radiotherapy plus cisplatin treatment for locally advanced non small cell lung cancer: preliminary results of a randomized study.
Preliminary results of a randomized study (radiotherapy versus radiotherapy plus weekly low-dose cisplatin) are reported. Fifty-four patients (43 evaluable) with stage IIIa-b non small cell lung cancer were randomized. Objective responses (CR + PR) were seen in 62% of the radiotherapy-treated group and in 63% of the group treated with radiotherapy plus cisplatin. No major toxicity was seen. Patient compliance for both treatments was satisfactory.
Clerici
M
M
Divisione di Oncologia Medica, Ospedale S. Carlo Borromeo, Milano, Italy.
Soresi
E
E
Zucali
R
R
Borghini
U
U
Vergani
C
C
Leoni
M
M
Botturi
F
F
Luporini
G
G
D000328:Adult; D000368:Aged; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D008875:Middle Aged; D011897:Random Allocation
D002945:Cisplatin